Denosumab is a new human monoclonal antibody that suppresses osteoclast function and thus inhibits bone resorption.
The FDA is requiring new boxed warnings on TNF-blockers regarding the risk of lymphoma and other malignancies in children and adolescents who have received the drugs.
The World Health Organization (WHO) has issued a global alert and response regarding the use of antivirals for pandemic H1N1 flu, reiterating that antivirals should be used to prevent severe illness and death in children and adults.
Physicians are prescribing fewer antibiotics for acute respiratory tract infections (ARTIs), but if an antibiotic is used, it is more likely to be a broad-spectrum drug.
A healthy 67-year-old man, Mr. C, comes to your office for his annual examination, which includes a check of his serum prostate specific antigen (PSA)...
WHO recommendations for antiviral use for H1N1 flu; antibiotic use trends for acute respiratory tract infection; denosumab clears FDA Expert Panel; FDA Actions.
